← Back to Search

Laxative

Split-dose PEG Based Lavage (2L + 2L) + Low-fiber Diet for Colorectal Cancer (BP Trial)

N/A
Waitlist Available
Led By Alaa Rostom, MD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients between 18 to 74 Years referred to the Forzani & MacPhail Colon Cancer Screening Centre in Calgary, Alberta, Canada for Colonoscopy will be considered for inclusion.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up questionnaire given on the day of pre-screen will be collected on the day of colonoscopy, approximately 3 weeks. patients are not followed or contacted past the day of colonoscopy.
Awards & highlights

BP Trial Summary

The objective of the study is to examine the effect of adding a strict low-residue lunch on the day before colonoscopy has on clinical efficacy and patient tolerability of bowel preparation, with patients receiving split-dose Polyethylene Glycol Based Lavage. The primary outcomes will be 1) quality of preparation in cleansing the colon and 2) patient satisfaction

Eligible Conditions
  • Colorectal Cancer

BP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

BP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~questionnaire given on the day of pre-screen will be collected on the day of colonoscopy, approximately 3 weeks. patients are not followed or contacted past the day of colonoscopy.
This trial's timeline: 3 weeks for screening, Varies for treatment, and questionnaire given on the day of pre-screen will be collected on the day of colonoscopy, approximately 3 weeks. patients are not followed or contacted past the day of colonoscopy. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quality of Bowel Cleanliness
Secondary outcome measures
Patient satisfaction with preparation

BP Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Split-dose PEG Based Lavage (2L + 2L) + Low-fiber DietActive Control1 Intervention
Patients randomized to this arm will have a split-dose Polyethylene Glycol Based lavage (2L + 2L), have a low-fibre diet 4 days prior to Colonoscopy and the day before Colonoscopy, have a low-fibre breakfast, a low-fibre lunch by 2PM and then drink only clear fluids until after the procedure is completed.
Group II: Split-dose PEG Based Lavage (2L + 2L) + Clear fluid dietPlacebo Group1 Intervention
Patients randomized to this arm will have a split-dose Polyethylene Glycol Based lavage (2L + 2L), have a low-fibre diet 4 days prior to Colonoscopy and the day before Colonoscopy, have a low-fibre breakfast and then drink only clear fluids until after the procedure is completed.

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
792 Previous Clinical Trials
868,809 Total Patients Enrolled
Alaa Rostom, MDPrincipal InvestigatorUniversity of Calgary
1 Previous Clinical Trials
171 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Split Dose Polyethylene Glycol (PEG) + Clear Fluids Versus Split Dose PEG + Low-Residue Diet
Alaa Rostom 2011. "Split Dose Polyethylene Glycol (PEG) + Clear Fluids Versus Split Dose PEG + Low-Residue Diet". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01610895.
All > Flu
~26 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top